Jump Financial »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Jump Financial

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Jump Financial from 13F filings

Historical chart of Jump Financial investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Jump Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Jump Financial

Quarter filed Position value Share count Share price at filing
2024-12-31 $5.4M 5.0M 1.08

More positions owned by Jump Financial

Invesco QQQ Trust Series 1 Etf (QQQ)
iShares Russell 2000 ETF Etf (IWM)
NVIDIA Corp Common Stock (NVDA)
SPDR S&P 500 ETF Trust Etf (SPY)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Alphabet Common Stock (GOOGL)
iShares iBoxx $ High Yield Corporate Bond ETF Etf (HYG)
Amazon.com Common Stock (AMZN)
Meta Platforms Common Stock (META)
Consumer Discretionary Select Sector SPDR Fund Etf (XLY)
Broadcom Common Stock (AVGO)
iShares U.S. Treasury Bond ETF Etf (GOVT)
Netflix Common Stock (NFLX)
Palantir Technologies Common Stock (PLTR)

View all positions for Jump Financial

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

Millennium Management
LMR Partners
Calamos Advisors
Camden Asset Management
Balyasny Asset Management
DLD Asset Management
Point72 Asset Management
Davidson Kempner Capital Management
Jpmorgan Chase & Co
Jain Global
Nuveen
Lazard Asset Management
State Street Corporation
Absolute Investment Advisers
Citadel Advisors

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1